Metabolic score for insulin resistance predicts major adverse cardiovascular event in premature coronary artery disease
CONCLUSIONS: METS-IR serves as a reliable prognostic predictor of MACE in patients with premature CAD. Therefore, METS-IR may be considered a novel, cost-effective, and dependable indicator for risk stratification and early intervention in premature CAD.PMID:38568104 | DOI:10.18632/aging.205710
Source: Aging - Category: Biomedical Science Authors: Dachuan Guo Chong Zhang Mingyan Zhang Zhenguo Wu Xiaoyu Liu Yerui Zhang Li Liu Meili Sun Jianmin Yang Source Type: research
More News: Biomedical Science | Cardiology | Cardiovascular | Heart | Heart Attack | Insulin | Statistics | Stroke | Study